Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma
Journal of Investigative Dermatology (2022) - Comments
pubmed: 34695412  doi: 10.1016/j.jid.2021.09.030  issn: 0022-202x  issn: 1523-1747 

Farzana Ahmed, Hsin-Yi Tseng, Antonio Ahn, Dilini Gunatilake, Sara Alavi, Michael Eccles, Helen Rizos, Stuart J Gallagher, Jessamy C Tiffen, Peter Hersey, Abdullah Al Emran